Hours postinjury | GFAP | UCH-L1 | Combination of GFAP and UCH-L1 |
Enrolment (children) (n=128) | 0.64 (0.54–0.73) | 0.54 (0.43–0.66) | 0.63 (0.53–0.72) |
Enrolment (adults) (n=392) | 0.66 (0.61–0.71) | 0.58 (0.51–0.64) | 0.66 (0.61–0.72) |
Enrolment (both) (n=520) | 0.65 (0.60–0.70) | 0.56 (0.51–0.62) | 0.65 (0.60–0.70) |
4 hours (n=421) | 0.62 (0.57–0.68) | 0.55 (0.49–0.61) | 0.62 (0.57–0.88) |
8 hours (n=99) | 0.72 (0.61–0.82) | 0.61 (0.49–0.73) | 0.72 (0.61–0.82) |
12 hours (n=74) | 0.69 (0.55–0.82) | 0.51 (0.37–0.66) | 0.67 (0.54–0.80) |
16 hours (n=69) | 0.76 (0.64–0.88) | 0.58 (0.39–0.76) | 0.74 (0.62–0.85) |
20 hours (n=65) | 0.68 (0.53–0.83) | 0.41 (0.23–0.59) | 0.66 (0.52–0.81) |
24 hours (n=64) | 0.74 (0.60–0.88) | 0.40 (0.24–0.56) | 0.72 (0.59–0.86) |
36 hours (n=44) | 0.76 (0.61–0.91) | 0.56 (0.37–0.75) | 0.76 (0.61–0.92) |
48 hours (n=38) | 0.81 (0.67–0.95) | 0.52 (0.32–0.73) | 0.79 (0.64–0.93) |
60 hours (n=31) | 0.86 (0.73–1.00) | 0.54 (0.34–0.74) | 0.86 (0.73–1.00) |
72 hours (n=30) | 0.78 (0.60–0.95) | 0.43 (0.20–0.66) | 0.71 (0.51–0.91) |
84 hours (n=19) | 0.84 (0.65–1.00) | 0.37 (0.13–0.62) | 0.74 (0.52–0.97) |
96 hours (n=16) | 0.75 (0.51–0.99) | 0.28 (0.02–0.55) | 0.65 (0.38–0.91) |
108 hours (n=8) | 0.67 (0.26–1.00) | 0.17 (0–0.47) | 0.33 (0–0.71) |
120 hours (n=7) | 0.80 (0.46–1.00) | 0.20 (0–0.58) | 0.70 (0.30–1.00) |
132 hours (n=4) | 0.75 (0.20–1.00) | 0 (0–0) | 0.50 (0–1.00) |
144 hours (n=6) | 0.75 (0.20–1.00) | 0 (0–0) | 0.50 (0.01–0.99) |
156 hours (n=6) | 0.75 (0.34–1.00) | 0 (0–0) | 0.50 (0.01–0.99) |
168 hours (n=4) | 0.75 (0.20–1.00) | 0.13 (0–1.00) | 0.63 (0–1.00) |
In this table, performance of GFAP and UCH-L1 alone and in combination is shown.
GFAP, glial fibrillary acidic protein; UCH-L1, ubiquitin C-terminal hydrolase.